September 2023

Header stock image

Maintaining Fidelity to ACT – Guide

SAMHSA has issued a new practical guide on Maintaining Fidelity to ACT: Current Issues and Innovations in Implementation.  To support continued efficacy of Assertive Community Treatment (ACT), it is critical to reaffirm its fundamentals and promote awareness of new developments relevant to implementation of the model.  Serving as a follow-up and companion product to SAMHSA’s Assertive

Maintaining Fidelity to ACT – Guide Read More »

Engaging Community Coalitions to Decrease Opioid Overdose deaths

Engaging Community Coalitions Guide

Today, SAMHSA, in collaboration with RTI International, is releasing the following resource intended to aid community practitioners in the ongoing work to end the overdose crisis. “Engaging Community Coalitions to Decrease Opioid Overdose Deaths”.  This product will equip public health practitioners, coalitions, nonprofits, and other groups working to prevent opioid-related death in their local communities

Engaging Community Coalitions Guide Read More »

Header image

ORCCA Practice Guide

Today, SAMHSA, in collaboration with RTI International, is releasing the following resource intended to aid community practitioners in the ongoing work to end the overdose crisis. Opioid-Overdose Reduction Continuum of Care Approach (ORCCA) and it is available for free online.   This product will equip public health practitioners, coalitions, nonprofits, and other groups working to prevent

ORCCA Practice Guide Read More »

Both save lives poster hanging on wall

Both Save Lives – AED (Poster)

Naloxone is a safe, life-saving medication that can reverse an overdose from opioids.  Termed an ‘opioid overdose reversal medication’, Naloxone is easy to carry and administer. This poster illustrates the comparison of Naloxone with an automated external defibrillator (AED), another life-saving tool. Naloxone frequently asked questions Naloxone trainings / videos Other naloxone resources Hard copies

Both Save Lives – AED (Poster) Read More »